The Position
A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Genentech, a member of the Roche Group.
The Opportunity
The Head of Translational Safety (TS) Digital Pathology Analytics provides the strategic vision, scientific and technical direction, and operational leadership for the Translational Safety Digital Pathology group. The successful Sr Principal Sci-Pathologist candidate will lead efforts focused on driving applications for digital pathology in the field of toxicologic pathology and predictive nonclinical safety evaluation, thereby contributing to the efficient, comprehensive, and integrated safety profiling of Genentech drug candidates from the Research stage through marketed products. This includes managing a team of AI/ML scientists to create and implement novel, state-of-the-art analytical and computational approaches aimed at improving the efficiency of pathology workflows and enhancing the acquisition and interpretation of high-quality quantitative morphologic data obtained from in vivo studies and in vitro methodologies. This position is also responsible for engaging and directing cross-functional digital pathology collaborations throughout the Genentech/Roche organization.
In this role, you will:
Manage strategy and team to advance digital pathology efforts to achieve TS, gRED, and Roche-wide cross-functional goals
Collaborate with project pathologists and toxicologists to align digital pathology goals with the evolving therapeutic portfolio
Represent TS as a primary gRED digital pathology contact for fostering collaboration and coordination on decisions with global organization-wide impact and significance
Influence the informatics and computational strategies across the global Roche organization and drive highly impactful initiatives internally and externally
Budget and resource planning responsibility (horizon of ~1 year), including the evaluation and application of emerging technologies (hardware and software)
Manage 5-10 FTEs or contractors
Who you are
D.V.M. and Ph.D. or equivalent curriculum. Diplomate in either the American or European College of Veterinary Pathology
Expertise in the application of digital pathology, image analysis, machine learning, and/or computer vision to pathology and biology
10+ years of relevant drug development experience and at least 4 years of management experience
Demonstrated outstanding leadership and effective management in scientific, technical, and/or operational areas, with the ability to lead toward organizational goals across functions
Strong reputation as a manager and mentor
Sustained record of impactful performance, strategic insight in advancing drug development
This role will be based in South San Francisco, and relocation benefits are available
The expected salary range for this position, based on the primary location of California, is $198,900 - $369,300. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below.
Benefits
Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws.
If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants.
Top Skills
What We Do
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal.
Making a difference in the lives of millions starts when you make a change in yours.
